Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Stock Information for Renovaro Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Renovaro Inc.

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Renovaro Announces $15 million in Equity Committed
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Renovaro Issues Shareholder Letter and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.